SILK NASDAQ
Silk Road Medical, Inc
1W: +0.0%
1M: +1.4%
3M: +2.2%
1Y: +75.3%
3Y: -51.9%
5Y: -20.5%
$27.49
Last traded 2024-09-26 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$177M
+27.8% ▲
5Y CAGR: +38.7%
Gross Profit
$127M
+26.1% ▲
5Y CAGR: +39.9%
Operating Income
-$59M
-14.0% ▼
Net Income
-$56M
+3.9% ▲
EPS (Diluted)
$-1.44
+11.1% ▲
EBITDA
-$45M
+3.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $63M | $75M | $101M | $139M | $177M |
| YoY Growth | +83.3% | +18.7% | +34.9% | +36.6% | +27.8% |
| Cost of Revenue | $16M | $21M | $25M | $38M | $50M |
| Gross Profit | $47M | $54M | $76M | $101M | $127M |
| Gross Margin | 74.9% | 71.7% | 74.9% | 72.7% | 71.7% |
| R&D Expenses | $12M | $21M | $27M | $36M | $41M |
| SG&A Expenses | $63M | $76M | $96M | $116M | $145M |
| Operating Expenses | $75M | $97M | $123M | $153M | $186M |
| Operating Income | -$28M | -$43M | -$47M | -$52M | -$59M |
| Operating Margin | -44.3% | -57.0% | -46.8% | -37.5% | -33.5% |
| Interest Expense | $5M | $4M | $3M | $5M | $7M |
| Income Before Tax | -$52M | -$47M | -$50M | -$55M | -$56M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$56M | -$50M | -$50M | -$58M | -$56M |
| Net Margin | -88.5% | -67.0% | -49.7% | -41.8% | -31.5% |
| EPS (Diluted) | $-2.44 | $-1.53 | $-1.45 | $-1.62 | $-1.44 |
| EBITDA | -$46M | -$41M | -$46M | -$47M | -$45M |
| Shares Outstanding | 23M | 33M | 35M | 36M | 39M |